QT
OPRX icon

Quantbot Technologies’s OptimizeRx OPRX Stock Holding History

Quantbot Technologies’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,847
Closed -$121K – 2036
2025
Q4 		$121K Buy
+9,847
New +$161K ﹤0.01% 1375
2025
Q3 		– Sell
-3,292
Closed -$44.4K – 2014
2025
Q2 		$44.4K Buy
+3,292
New +$36K ﹤0.01% 1494
2024
Q2 		– Sell
-5,262
Closed -$63.9K – 1788
2024
Q1 		$63.9K Buy
5,262
+676
+15% +$9.8K ﹤0.01% 1291
2023
Q4 		$65.6K Sell
4,586
-1,717
-27% -$16.5K ﹤0.01% 1283
2023
Q3 		$49K Buy
+6,303
New +$68.6K ﹤0.01% 1248
2023
Q2 		– Sell
-14,707
Closed -$215K – 1851
2023
Q1 		$215K Buy
14,707
+12,121
+469% +$203K 0.02% 888
2022
Q4 		$43.4K Sell
2,586
-12,264
-83% -$212K ﹤0.01% 1327
2022
Q3 		$220K Buy
+14,850
New +$294K 0.02% 853
2022
Q1 		– Sell
-8,501
Closed -$527K – 1947
2021
Q4 		$527K Buy
+8,501
New +$644K 0.04% 520

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's OPRX Position: Q1 2026 in Review

Quantbot Technologies sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 9,847 shares — an estimated $121K sold.

Quantbot Technologies first reported a position in OPRX in Q4 2021 and held it in 9 quarters. The position peaked at $527K in Q4 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Quantbot Technologies reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 9,847 OptimizeRx shares in Q1 2026, an estimated $121K.
  • Quantbot Technologies first reported a position in OptimizeRx in Q4 2021 and held it in 9 quarters.
  • Quantbot Technologies's OptimizeRx position peaked at $527K in Q4 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.